| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/26/2006 | EP1341532B1 Use of pyridoxamine for the treatment and inhibition of obesity-related complications |
| 07/26/2006 | EP1313472A4 Method for reducing or eliminating smoking |
| 07/26/2006 | EP1311297B1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 07/26/2006 | EP1301190B1 Pepsin inhibition by alginates |
| 07/26/2006 | EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 07/26/2006 | EP1244451B1 Substituted piperazine and piperidine calcium channel blockers |
| 07/26/2006 | EP1242067B1 Calcium formate as a dietary supplement |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP1216025B1 Dispersion formulations containing lipase inhibitors |
| 07/26/2006 | EP1196161B1 Conjugated linoleic acid for treatment of cyclooxygenase-2 mediated inflammation and pain |
| 07/26/2006 | EP1192950B1 Therapeutic drugs for dermatitis exhibiting a biphasic skin reaction containing chymase inhibitors as the active ingredient |
| 07/26/2006 | EP1189915B1 Process for the production of azithromycin |
| 07/26/2006 | EP1162937B1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration |
| 07/26/2006 | EP1082338B1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/26/2006 | EP1072273B1 Vascularization inhibitors |
| 07/26/2006 | EP1036073B1 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| 07/26/2006 | EP1027069B1 Gene therapy for gaucher disease |
| 07/26/2006 | EP0979817B1 Leukotriene a4 hydrolaze inhibitors |
| 07/26/2006 | EP0934424B1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 07/26/2006 | EP0929303B1 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent |
| 07/26/2006 | EP0904100B1 Cationic lipid and receptor ligand-facilitated delivery of biologically active molecules |
| 07/26/2006 | EP0902003B1 Novel tetralone or benzopyranone derivatives and process for producing the same |
| 07/26/2006 | EP0866711B1 Montirelin for inhibiting sleep apnea |
| 07/26/2006 | EP0835136B1 Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate |
| 07/26/2006 | EP0831804B1 Methods for maintaining or elevating the cd-4 or cd-8 cell levels comprising the administration of conjugated linoleic acid; a new process for the manufacture of conjugated linoleic acid using lactobacillus sp |
| 07/26/2006 | EP0801527B1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
| 07/26/2006 | EP0788346B1 Emulsified drug delivery systems |
| 07/26/2006 | CN2798992Y Broad-spectrum vaccine generator for treating viral infectious disease |
| 07/26/2006 | CN2798943Y Cicatrix plaster |
| 07/26/2006 | CN2798942Y Aspirin dipyridamole slow-release tablet |
| 07/26/2006 | CN1809594A Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same |
| 07/26/2006 | CN1809584A Compositions comprising cationic microparticles and HCV E1E2 DNA and methods of use thereof |
| 07/26/2006 | CN1809583A Antisense oligonucleotides that inhibit expression of hif-1 |
| 07/26/2006 | CN1809581A Alkylamino alkoxyl substituted C-glycosylisoflavones and preparing method and the use of the same |
| 07/26/2006 | CN1809576A Antiparasitic terpene alkaloids |
| 07/26/2006 | CN1809575A Thienopyridone derivatives as kinase inhibitors |
| 07/26/2006 | CN1809574A Quinoline 3-amino chroman derivatives |
| 07/26/2006 | CN1809573A Tricyclic indole derivatives and their use in the treatment of alzheimer's disease |
| 07/26/2006 | CN1809572A Substituted quinobenzoxazine analogs |
| 07/26/2006 | CN1809570A [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 07/26/2006 | CN1809569A Pyrimido compounds |
| 07/26/2006 | CN1809567A Novel imidazopyridine compound ii with therapeutic effect |
| 07/26/2006 | CN1809566A Cannabinoid receptor ligands and uses thereof |
| 07/26/2006 | CN1809565A Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 07/26/2006 | CN1809564A Pyrrolodihydroisoquinolines as PDE10 inhibitors |
| 07/26/2006 | CN1809563A Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| 07/26/2006 | CN1809561A Phenylacetamides and their use as glucokinase modulators |
| 07/26/2006 | CN1809560A Thiazolylpiperidine derivatives as mtp inhibitors |
| 07/26/2006 | CN1809559A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 07/26/2006 | CN1809558A 4-(aminomethyl)-piperidine benzamides as 5HT4 -antagonists |
| 07/26/2006 | CN1809557A 化合物 Compound |
| 07/26/2006 | CN1809556A Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 07/26/2006 | CN1809555A Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases |
| 07/26/2006 | CN1809552A Cannabinoid derivatives, methods of making, and use thereof |
| 07/26/2006 | CN1809551A Flavanone compound and uses thereof |
| 07/26/2006 | CN1809545A N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5HT2c |
| 07/26/2006 | CN1809544A Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/26/2006 | CN1809542A Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof. |
| 07/26/2006 | CN1809541A Aniline derivatives |
| 07/26/2006 | CN1809540A Inhibitors of Akt activity |
| 07/26/2006 | CN1809536A Inhibitors of Akt activity |
| 07/26/2006 | CN1809531A Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 07/26/2006 | CN1809529A Pharmaceutically useful salts of carboxylic acid derivates |
| 07/26/2006 | CN1809385A Peg-wortmannin conjugates |
| 07/26/2006 | CN1809384A Chemical combination and method for increasing delivery of coenzyme Q 10 |
| 07/26/2006 | CN1809382A A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
| 07/26/2006 | CN1809371A Lyase treatment for p. carinii |
| 07/26/2006 | CN1809367A A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 07/26/2006 | CN1809366A Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (TGEV) |
| 07/26/2006 | CN1809365A Use of adenosine receptor agonists in therapy |
| 07/26/2006 | CN1809364A Compositions and methods for increasing telomerase activity |
| 07/26/2006 | CN1809363A Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase |
| 07/26/2006 | CN1809362A Substituted 1,4-diazepines and uses thereof |
| 07/26/2006 | CN1809361A Use of 2h-[1,3]-oxazino[3,2-a]indole derivatives for the treatment of neuropathic pain |
| 07/26/2006 | CN1809360A 4-anilino-quinazoline derivatives as antiproliferative agents |
| 07/26/2006 | CN1809359A Combinations comprising paroxetine and 2-(S)-(4-fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoro-2-methyl-phenyl)-ethyl]-methyl amide for treatment of depression and/or a |
| 07/26/2006 | CN1809358A Polymorphs of cabergoline |
| 07/26/2006 | CN1809357A Small molecule Toll-like receptor (TLR) antagonists |
| 07/26/2006 | CN1809356A Use of indazole derivatives for the treatment of neuropathic pain |
| 07/26/2006 | CN1809355A Combinations comprising paroxetine and 2-(S)-(4-fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoro-2-methyl-phenyl)-ethyl]-methyl amide for treatment of depression and/or a |
| 07/26/2006 | CN1809354A Akt活性抑制剂 Akt activity inhibitor |
| 07/26/2006 | CN1809353A Medicine for prevention of and treatment for arteriosclerosis and hypertension. |
| 07/26/2006 | CN1809352A Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis |
| 07/26/2006 | CN1809351A Inhibitors of Akt activity |
| 07/26/2006 | CN1809350A Aboxadol for treating depression and other affective disorders |
| 07/26/2006 | CN1809349A 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine A2A receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation |
| 07/26/2006 | CN1809348A Pharmaceutical formulations comprising amoxicillin and clavulanante |
| 07/26/2006 | CN1809347A Selective spirocyclic glucocorticoid receptor modulators |
| 07/26/2006 | CN1809346A Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor XA and VIIA inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then |
| 07/26/2006 | CN1809345A Enalapril-nitroxyderivatives derivatives and related compounds as ACE inhibitors for the treatment of cardiovascular diseases |
| 07/26/2006 | CN1809344A Antioxidant combination composition and use thereof |
| 07/26/2006 | CN1809343A Fast dissolving orally consumable films containing a sucralose as a sweetener |
| 07/26/2006 | CN1809342A Fluvastatin-containing tablet |
| 07/26/2006 | CN1809340A Pharmaceutical products |
| 07/26/2006 | CN1809339A Oil emulsion for postnatal hormone substitution |
| 07/26/2006 | CN1809287A Composition and foods for lowering glycemic index |
| 07/26/2006 | CN1809285A Movement physiology improver |
| 07/26/2006 | CN1809284A Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides and oxidative stress |
| 07/26/2006 | CN1807466A Method for producing low viscosity algin |
| 07/26/2006 | CN1807463A White fungus heteropolysaccharide and its extract, preparation method and uses |